key: cord-0854526-tu7k52uo authors: Hassan, S.K. Sarif; Choudhury, Pabitra Pal; Roy, Bidyut title: Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes date: 2021-02-18 journal: Meta Gene DOI: 10.1016/j.mgene.2021.100873 sha: 74fc89ff0e6c9e691d0ab1bd0b840e512859a137 doc_id: 854526 cord_uid: tu7k52uo A total number of 3080 SARS-CoV-2 genomes from all continents are considered from the NCBI database. Every accessory protein ORF6, ORF7b, and ORF10 of SARS-CoV-2 possess a single missense mutation in less than 1.5% of the 3080 genomes. It has now been observed that different non-synonymous mutations occurred in these three accessory proteins. Most of these rare mutations are changing the amino acids such as hydrophilic to hydrophobic, acidic or basic to hydrophobic, and vice versa etc. So these highly conserved proteins might play an essential role in virus pathogenicity. This study opens a question whether it carries some messages about the virus rapid replications, and virulence. The accessory proteins of SARS-CoV-2 help the virus to infect its human host, replicate, and eventually spread from person to person. There are six accessory proteins ORF3a, ORF6, ORF7a, ORF7b, ORF8, and ORF10 in the SARS-CoV-2 genomes, which play important roles in the viral life cycle, and may contribute to the pathogenesis and virulence [1] . These accessory proteins are unique to SARS-CoV-2, as they have least homology in amino acid sequence with accessory proteins of other coronaviruses. These proteins contribute to virus virulence though it does not directly affect the virus release, stability and pathogenesis [1] . Therefore, close observations and understanding of these proteins may explain the differences in pathogenicity between SARS-CoV-2, and other known coronaviruses. Within a very quick time span, SARS-CoV-2 virus has been evolving for accounting various missense mutations in various proteins. It has been already observed by us that except one in ORF7b, there are no missense mutations over the proteins ORF6, and ORF10 across the SARS-CoV-2 genomes detected in 128 Indian patients [2, 3] . Missense mutations in the accessory proteins of SARS-CoV-2 might impact in heterogeneity of SARS-CoV-2 and may contribute to comprehending the pathogenic dynamics as well as virulence of the virus over time. The amino acid mutations among SARS-CoV-2 isolates from diverse locations could be linked with their geographical distributions. This rapidly evolving virus is capable of adapting swiftly to the diverge environments [4] . So it is quite important to discover whether any missense mutations are found in those proteins across the SARS-CoV-2 genomes worldwide, other than India. Here we present the some known reported functions of three accessory proteins ORF6, ORF7b, and ORF10 as follows: • ORF6: This protein contains a hydrophobic N-terminal, and it has been suggested to have a N-endo-C-endo conformation [5] . The ORF6 protein makes intracellular membrane rearrangements resulting in a vesicular population in the infected cell which could possibly serve some role in increasing replication of the virus [6] . It has been previously reported that ORF6 down-regulated the mRNA level of the co-transfected myc-nsp8 gene [7] . It is also reported that amino acids 53-56 in ORF6 of SARS-CoV constitute a putative diacidic motif (DDEE) which influences the suppression of the expression of co-transfected myc-nsp8 [5] . • ORF7b: ORF7b is very much unique since it does not have any sequence homology with other viral proteins [8] . The accessory protein ORF7b has been reported to have a structural component in the SARS-CoV virions [9] . The transmembrane domain of ORF7b is essential to retain the protein in the Golgi compartment [10] . It has been found that ORF7b of SARS-CoV-2 is 81% identical to that of SARS-CoV. It is J o u r n a l P r e -p r o o f Journal Pre-proof reported that absence of ORF7b does not affect virus replication [9] . Alanine scanning experiments showed that the amino acids in 13-15, and 19-22 are critical for the retention of ORF7b in the Golgi complex [10] . • ORF10: ORF10 protein is the unique accessory protein in SARS-CoV-2 as it does not present in the SARS-CoV [11] , and hence it is sometimes called "mysterious protein". The signature appearance of ORF10 in SARS-CoV-2 makes the novel coronavirus easily detectable compared to other PCR based methods [12] . Function of this protein is still undiscovered. Therefore any missense mutation in ORF10 is significantly worth determining, and requires further investigations in order to understand the functions of ORF10. All the protein sequences of 3080 SARS-CoV-2 genomes are fetched from the NCBI virus database. Then for each of the three accessory proteins, amino acid sequences are exported in fasta format using file operations through Matlab. For each accessory protein, these sequences (fasta formatted) are blasted using Clustal-Omega, and found the mutations and accordingly their associated positions are accounted [13] . It is to be noted that among these virus genomes from 3080 patients, there are 2126 genomes from USA, 306 from Asia, 281 genomes from Europe, 365 genomes from Oceania and one genome from Africa. Here (Table 1) , we present the missense mutations of the three accessory proteins ORF6, ORF7b, and ORF10 over the available 3080 SARS-CoV-2 genomes. Note that the mutation of an amino acid 1 A to an amino acid 2 A is denoted by 12 () A l A where l denotes location in the reference amino acid sequence. In Table 1 , also the changes of the R-group of each amino acid according to the mutations are presented. The Table 1 depicts the following: Table 1 . This motif DEEQ of ORF6 has been mutated (D(53)Y) to YEEQ in QJR89461-ORF6 (Australia: Victoria). Strikingly, the motif DEEQ mutated (D(53)G) to GEEQ in the ORF6 protein across the 25 SARS-CoV-2 genomes from USA:CA as shown in Table 2 . These missense mutations may affect the suppression of the expression of co-transfected myc-nsp8. The novel RNA virus SARS-CoV-2 has been evolving through several mutations over the associated proteins within a very short time from its discovery since December, 2019. It has now been observed that few mutations occurred in these three proteins. As we see here, the total amount of mutations possessed by three accessory proteins ORF6, ORF7b, and ORF10 is around 1.5%. Since the mutations are few, we firmly believe that these mutated protein variants are beneficial for virus. This study opens a question whether it carries some messages about the virus rapid replications and virulence and their role in pathogenicity. Whether these mutations raise different symptoms in the affected patients, is certainly of worth investigation from the pathogenetic perspective. These conserved proteins may suggest for development of antiviral drugs or formulate new vaccines from a new starting point. Since the mutations are rare in numbers, we firmly believe that these mutated protein variants might elongate sustainability and pathogenicity of the virus. It will also be interesting to explore whether these rare mutations were evolved from China or other affected continents/countries. Recently, two variants 202012 / 01 VUI  and 501. 2 V of SARS-CoV-2 (first detected in Europe and South Africa, respectively) became a concern to the world population due to the spread in different countries [14] , GISAID. Of these two, VUI-202012/01 has more transmission ability. Sequence analysis has shown that these variants have mutations in S, N, NSP etc. genes and none of them has mutation in ORF6, ORF7b, and ORF10. So, it corroborates to our observation that these ORF proteins are highly conserved in the SARS-CoV2 genome. Although the clinical importance of these rare mutations are yet to be discovered, this study certainly would serve as a groundwork. SH conceived the problem. SH determined the mutations. SH, PPC, and BR analysed the data and result. SH wrote the initial draft which was checked and edited by all other authors to Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein Missense mutations in sars-cov2 genomes from indian patients Molecular conservation and differential mutation on orf3a gene in indian sars-cov2 genomes Genome-wide analysis of sars-cov-2 virus strains circulating worldwide implicates heterogeneity A putative diacidic motif in the sars-cov orf6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs Severe acute respiratory syndrome coronavirus orf6 antagonizes stat1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/golgi membrane The n-terminal region of severe acute respiratory syndrome coronavirus protein 6 induces membrane rearrangement and enhances virus replication The orf7b protein of severe acute respiratory syndrome coronavirus (sars-cov) is expressed in virus-infected cells and incorporated into J o u r n a l P r e -p r o o f Journal Pre-proof sars-cov particles Structure, expression, and intracellular localization of the sars-cov accessory proteins 7a and 7b The transmembrane domain of the severe acute respiratory syndrome coronavirus orf7b protein is necessary and sufficient for its retention in the golgi complex Direct rna sequencing and early evolution of sars-cov-2, bioRxiv Variant analysis of covid-19 genomes The embl-ebi search and sequence analysis tools apis in 2019 Genome sequence of a sars-cov-2 vui 202012/01 strain identified from a patient returning from london, england, to the apulia region of italy Research Highlights:  Every accessory protein viz. ORF6, ORF7b, and ORF10 of SARS-CoV-2 possess a single missense mutation in less than 1.5\% of the 3080 genomes  It has now been observed that most of these rare mutations are changing the amino acids such as hydrophilic to hydrophobic, acidic or basic to hydrophobic, and vice versa etc. So these mutations might have significant effect on the corresponding protein functions, and consequently might play an essential role in virus pathogenicity This study opens a question whether it carries some messages about the virus rapid replications, and virulence The authors do not have any conflicts of interest to declare.